Searched over 200M research papers
10 papers analyzed
Some studies suggest hyperbaric oxygen therapy (HBOT) may improve wound healing and cognitive outcomes in certain conditions, while other studies indicate mixed results and potential adverse reactions, highlighting the need for further research to clarify its effectiveness and safety.
20 papers analyzed
Hyperbaric oxygen therapy (HBOT) involves breathing pure oxygen in a pressurized chamber, which increases oxygen levels in the blood and tissues. This treatment has been explored for various medical conditions, including chronic wounds, traumatic brain injuries, and cognitive impairments.
HBOT has shown promise in treating chronic wounds, particularly diabetic foot ulcers. Studies indicate that HBOT can significantly improve the healing rate of diabetic foot ulcers in the short term, although this benefit does not persist in the long term . Despite these findings, the evidence is not robust due to methodological flaws in the trials, and more high-quality research is needed to confirm these results.
For venous ulcers, HBOT has demonstrated a significant reduction in ulcer area at six weeks, but the long-term benefits remain unclear. Similarly, for mixed ulcer types, HBOT has shown a significant reduction in ulcer area after 30 days of treatment.
HBOT has also been investigated for acute surgical and traumatic wounds. Some studies suggest that HBOT can improve outcomes in skin grafting and trauma cases, such as burn wounds and crush injuries, by enhancing graft survival and reducing tissue necrosis. However, the evidence is limited and further high-quality trials are necessary to validate these findings.
The use of HBOT in traumatic brain injury (TBI) has been explored with mixed results. While HBOT has not shown significant benefits for mild TBI compared to sham treatments, it may offer some advantages for moderate to severe TBI by reducing ischemia and inflammation, thus preserving brain tissue. However, the complexity of brain injuries and methodological issues in studies necessitate further research to establish clear benefits.
HBOT's impact on cognitive functions has been studied in various neurological disorders. The results are controversial, with some studies indicating potential benefits while others do not. More precise and objective neuropsychological assessments are required to evaluate HBOT's efficacy in treating cognitive deficits comprehensively.
HBOT works by increasing oxygen delivery to tissues, which can help reduce hypoxia, inflammation, and ischemia-reperfusion injury. These mechanisms are particularly beneficial in conditions like refractory diabetic wounds and radiation injuries. However, the clinical utility of HBOT for other disorders remains to be fully clarified, and patient selection criteria need to be refined to improve cost-effectiveness.
While HBOT can be beneficial, it is not without risks. Adverse effects are more likely when the chamber pressure exceeds 2.0 ATA or when the treatment course is longer than 10 sessions. The most common side effect is ear discomfort, but other potential risks include oxygen toxicity and barotrauma. Therefore, careful monitoring and appropriate patient selection are crucial to minimize these risks.
Hyperbaric oxygen therapy offers potential benefits for various medical conditions, particularly chronic wounds and certain neurological disorders. However, the evidence is mixed, and further high-quality research is needed to confirm its efficacy and safety. Adverse effects are a concern, and careful patient selection and monitoring are essential to optimize outcomes.
Most relevant research papers on this topic